Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05597813

Topical Timolol 0.5% in Atrophic Acne Scar

Conditions: Acne Scars - Mixed Atrophic and Hypertrophic

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 30

Sponsor: Zagazig University

Summary

The aim of the study is to evaluate the efficacy and safety of microneedling combined with topical timolol 0.5% in the treatment of atrophic acne scars.

Eligibility Criteria

Inclusion Criteria:All types of facial atrophic acne scarsPatients aged >18 yearsBoth sexesExclusion Criteria:Pregnancy and lactationActive acne or any active facial lesionHistory of keloid scarHistory of systemic diseases as DM or hypotensionBleeding and coagulation disordersInfection and immunosuppression

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05597813). StuddyBuddy aggregates publicly available trial information.